Baxter (BAX) Tops Q3 EPS by 6c, Revenues Beat; Offers FY18 EPS Outlook
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/14/2026
- Tech stocks pull Wall Street lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
Baxter (BAX) Receives CE Mark for PrisMax
October 29, 2018 7:12 AM EDTBaxter International Inc. (NYSE: BAX), a global leader in acute care, announced today the company received CE mark of both its PrisMax system and its TherMax blood warmer. PrisMax is the companys next-generation technology for continuous renal replacement and organ support therapies. Designed with input from more than 650 healthcare practitioners around the world, the PrisMax system features innovative technology to make delivering therapy simpler and more efficient while also improving treatment accuracy in the ICU. Baxter kicked off the launch of the PrisMax system at the 2018 European Society... More
